The 2023 Science paper reported taurine concentrations declining with age in mice, monkeys and humans. That single observation is what made taurine a longevity supplement.
In June 2025 the same journal published an NIH study asking whether the decline is real. Using longitudinal data — repeated measurements in the same individuals — across humans, rhesus monkeys and mice, it found circulating taurine increased or remained unchanged with age in three geographically distinct human cohorts: the Baltimore Longitudinal Study of Aging (ages 26–100), the Balearic Islands Study of Aging (20–85) and the Predictive Medicine Research cohort in Atlanta (20–68).
It also found that differences between any two individuals typically exceeded the change attributable to ageing. The authors concluded taurine is unlikely to serve as a good biomarker for ageing.
The working
(2 × 0.25) + (4 × 0.35) + (2 × 0.25) + (9 × 0.15) = 3.8
Scored as support for the claim. The disconfirming study used repeated measurements in the same individuals, which is the stronger design for a question about change over time.
- RCTFernandez ME, de Cabo R, et al. Is taurine an aging biomarker? Science 2025 · doi 10.1126/science.adl2116 · three human cohorts, longitudinal
- RevNIH: researchers conclude taurine is unlikely to be a good aging biomarker Levels increased or remained constant with age across species